Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer. - Wikidata - wikimedia - TriplyDB

Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

http://www.wikidata.org/entity/Q33697764

about

Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration Tiny giants of gene regulation: experimental strategies for microRNA functional studies Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression Evaluation and prognostic significance of ACAT1 as a marker of prostate cancer progression Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma miRNAs associated with prostate cancer risk and progression Evaluation of ERG responsive proteome in prostate cancer The SNAIL/miR-128 axis regulated growth, invasion, metastasis, and epithelial-to-mesenchymal transition of gastric cancer Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer.Regulation of NANOG in cancer cells.Suppression of CYP2C9 by microRNA hsa-miR-128-3p in human liver cells and association with hepatocellular carcinoma.An axis involving SNAI1, microRNA-128 and SP1 modulates glioma progression.Functions of MiRNA-128 on the regulation of head and neck squamous cell carcinoma growth and apoptosis.Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated absence in melanoma 2 (AIM2) inflammasomes.miR-128 exerts pro-apoptotic effect in a p53 transcription-dependent and -independent manner via PUMA-Bak axis.Biomarkers in prostate cancer epidemiology.The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions.miRNAs as biomarkers in prostate cancer.Novel approaches for the identification of biomarkers of aggressive prostate cancer Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.Seminal plasma as a diagnostic fluid for male reproductive system disorders.Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease.Identification of Transcription Factor YY1 as a Regulator of a Prostate Cancer-Specific Pathway Using Proteomic Analysis.Investigation of phosphoprotein signatures of archived prostate cancer tissue specimens via proteomic analysis.Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.MicroRNA: a connecting road between apoptosis and cholesterol metabolism.Proteomic screening and identification of microRNA-128 targets in glioma cells.Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells.A novel approach to identify driver genes involved in androgen-independent prostate cancer.Loss of SNAIL inhibits cellular growth and metabolism through the miR-128-mediated RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancer cells.Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.MicroRNA-128-3p regulates mitomycin C-induced DNA damage response in lung cancer cells through repressing SPTAN1 miR-128 downregulation promotes growth and metastasis of bladder cancer cells and involves VEGF-C upregulation.

P2860

Q24612001-06080DEB-124A-4C2D-B95B-1F0543CEB652 Q26767339-DEFD6670-7518-4792-9878-C0155634631C Q28082679-81E02605-084E-4E89-A359-D32546CEBABD Q28286300-FABD99F6-B94E-4100-A3FA-A75E8F7CDA2E Q28303423-93C5D7C2-0803-47C2-9A8D-31AED0AD57B4 Q28477463-6FE974E5-0BAC-4833-B7C2-81AB5F9A18CB Q30235186-FA6F9840-BB45-42DD-AD5C-60C5A5A2CD6B Q33822319-8C665B47-9E2F-42C1-B807-E4316F7DC827 Q33889165-AB6BF26A-2BDA-491B-930C-FB925A09E3C3 Q34107720-8484CCDE-CF3B-4F88-B610-9A567399DE32 Q34478004-1B2BB927-6050-4F47-974C-9F399C592C67 Q35109229-58EBA57B-955F-4B57-BA9B-6DC01B8A9151 Q35193962-53CC8166-6485-4EE3-BA34-62F5BE15D437 Q35575766-824DF685-C4C6-4900-A6DD-D64266EFEBA2 Q35644340-B5C55C6A-4B26-4664-811B-5E3B9D8C135B Q35873154-223D787A-2706-41AF-B3EB-8236204EA381 Q36298306-6C2D10A4-2EA0-483A-B203-1FC3C0C98FE8 Q36386982-0E439CE8-20E0-4CE6-BF72-B640A98D6CBB Q36733176-97103F96-906A-4D90-AC09-139272ED8D88 Q37148139-F6D42257-C8B4-4B56-8791-41CF7D8838FD Q38026940-6FAA6DCB-A9C9-4B29-BAA7-1F4C894C4AA9 Q38031424-48A259FB-B1EF-486D-A99E-68CC54A1D4A7 Q38117841-C9D996A6-5DE3-452C-8EB6-9A10291FC658 Q38189850-F74979E5-B0D9-45F2-A8F7-A74D6492A702 Q38202841-17B7E53D-4568-43A5-9610-18BC4C8950EB Q38260830-F91778A4-6752-4208-A556-D2E315A5CCA1 Q38378261-03DC824C-526B-4E60-ABAB-E354B6475A7D Q38384375-1AAB0F86-DD95-47E1-ACA8-058CA52D235A Q38399742-8076253A-DE37-4F21-802E-1D0DC05C4104 Q38409373-E4FF6DB4-E1C4-48C0-BD52-2B0C1FB818B7 Q38615085-BEA65569-84CA-45BC-954D-D37AD06D16FD Q38815056-A2F9C197-AC0B-46A1-88D8-CA19B14EC49B Q38898532-51476DD3-B391-475B-8E90-A17DFBB63B31 Q38908290-EEC9B4AE-7426-448C-AF26-440DF5F250DD Q38987842-D7AEC763-91A5-4C1A-B4C5-4ECD0704305B Q38989441-6E73435E-6AB5-4C71-BDD3-F1B579E0DB37 Q38991674-5FFB2ECE-8DF7-4273-9F59-75BEADFCDD58 Q40574583-59EE4590-2D12-42C1-8702-E81CE1791BD5 Q41709715-B83272B4-ADE5-4715-AABA-524A37C8E156 Q43148069-A47558DA-FA1E-46C9-98AE-C0AE8BCBD4D6

P2860

Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

http://www.wikidata.org/entity/Q33697764

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Quantitative proteomic profili ...... or miR-128 in prostate cancer.

@ast

Quantitative proteomic profili ...... or miR-128 in prostate cancer.

@en

type

label

Quantitative proteomic profili ...... or miR-128 in prostate cancer.

@ast

Quantitative proteomic profili ...... or miR-128 in prostate cancer.

@en

prefLabel

Quantitative proteomic profili ...... or miR-128 in prostate cancer.

@ast

Quantitative proteomic profili ...... or miR-128 in prostate cancer.

@en

P1433

Q33697764-1DD81FF3-95CD-49A7-82FB-BE5D1E4FEDE3

P1476

Q33697764-9111EFF9-00A5-4D55-8B04-EC80F89F53A7

P2093

Q33697764-191E4EAD-E98F-494A-A7FE-F3710E8AABCB

Q33697764-1CDB0690-D8D0-4911-B48C-BE2361AA7F4A

Q33697764-224CF552-F23D-41BB-AAF2-F1A88BDBE557

Q33697764-36EA971A-1F1E-4AA0-89A5-49E48045C9B0

Q33697764-57E66983-9406-4CE2-8AFB-503507F620FF

Q33697764-9371A825-0E01-4213-ABA7-3190F6ECED48

Q33697764-9E479042-11A4-470B-960A-5FF712D0F60F

Q33697764-FF1D47F5-90C2-4404-8087-2DA95B0A9F59

P2860

Q33697764-0023776C-B463-4845-AA4B-EDB3EB43CA4A

Q33697764-01A1AB45-5015-4EDE-B457-A570F12B515D

Q33697764-0370635C-1983-40C9-96B2-51B3FE4A7935

Q33697764-07E1AA5E-10F1-42A1-997D-C7A2D237CCA7

Q33697764-1029640F-B9E5-4B7C-9C03-B7D9B3C9BBAC

Q33697764-10788E97-A89A-4D76-927A-51F1BD7156B6

Q33697764-154648D0-FF43-4365-B052-42A065E24A67

Q33697764-1728198B-265D-4AB9-8914-B3650772B32E

Q33697764-1883A4C4-CB28-4B75-9992-D7D75076F884

Q33697764-19D1F814-83F8-4152-9A87-4864584BF6C5

P304

Q33697764-49F01755-BD1F-461F-A6AF-B0C26819AF68

P31

Q33697764-FB9FDAF8-44E1-4C42-A302-6970B9F11EC2

P356

Q33697764-EE296918-195A-4B83-836A-7AEE026513C0

P433

Q33697764-E19E7DD8-7D43-4DEB-899E-24599E0CC10C

P478

Q33697764-13D52558-E415-4A17-A9ED-0FB8BCD66E58

P50

Q33697764-264B4C72-EF0A-40A7-8C95-179262ACD6B8

Q33697764-7D6C167F-C97A-44CD-83FA-A8A0B82A0479

Q33697764-86440978-DF6D-470B-912D-48474DCC4548

P577

Q33697764-159F13A4-49EC-4876-B05A-EF044935BECC

P698

Q33697764-70141FC0-DE50-407E-BE0A-73637112438D

P932

Q33697764-98091E27-9659-409A-89A3-30DC2BBA499E

P356

MCP.M900159-MCP200

P1433

Molecular & Cellular Proteomics

P1476

Quantitative proteomic profili ...... or miR-128 in prostate cancer.

@en

P2093

Amjad P Khan

http://www.w3.org/2001/XMLSchema#string

Arul M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

Arun Sreekumar

http://www.w3.org/2001/XMLSchema#string

Damian Fermin

http://www.w3.org/2001/XMLSchema#string

George Michailidis

http://www.w3.org/2001/XMLSchema#string

Laila M Poisson

http://www.w3.org/2001/XMLSchema#string

Rong Zhao

http://www.w3.org/2001/XMLSchema#string

Vadiraja B Bhat

http://www.w3.org/2001/XMLSchema#string

P2860

The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer

Mortality results from a randomized prostate-cancer screening trial

Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Silencing of microRNAs in vivo with 'antagomirs'

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

Molecular portraits of human breast tumours

Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells

P304

298-312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M900159-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Alexey I. Nesvizhskii

Shanker Kalyana-Sundaram

P577

2009-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19955085

http://www.w3.org/2001/XMLSchema#string

P932

2830841

http://www.w3.org/2001/XMLSchema#string